Patents Assigned to Bigfoot Biomedical, Inc.
-
Patent number: 10835671Abstract: A method may include delivering insulin, using an insulin pump and a controller, over a first diurnal time period based on a baseline basal insulin rate stored in memory. The controller may receive blood glucose data to control delivery of insulin via the insulin pump in amounts variable from the baseline basal insulin rate to control blood glucose levels for a person with diabetes (PWD). The method may also include modifying the baseline basal insulin rate stored in the memory for a second diurnal time period that is at least 20 hours after the first diurnal period based on an amount of insulin actually delivered during the first diurnal time period.Type: GrantFiled: January 13, 2017Date of Patent: November 17, 2020Assignee: Bigfoot Biomedical, Inc.Inventors: Lane Desborough, Bryan Mazlish
-
Patent number: 10821228Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include adjusting user specific dosage parameters in response to a user provided insulin delivery amount, including a user provided insulin delivery amount that varies from a recommended insulin delivery amount.Type: GrantFiled: January 12, 2018Date of Patent: November 3, 2020Assignee: Bigfoot Biomedical, Inc.Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
-
Patent number: 10806859Abstract: A method may include displaying to a user an interface at which the user inputs a fear of hypoglycemia index (FHI), the FHI corresponding to an acceptable probability of a blood glucose level being below a threshold blood glucose level. The method may also include receiving blood glucose data for a person with diabetes (PWD). The method may additionally include calculating a probability of the PWD having a blood glucose level below the threshold blood glucose level based on the variability of the received blood glucose data. The method may also include setting one or more target blood glucose levels to align the probability of the PWD having a blood glucose level below the threshold blood glucose level with the acceptable probability associated with the user input FHI. The method may additionally include delivering insulin, using the insulin delivery device, based on the target blood glucose level.Type: GrantFiled: January 13, 2017Date of Patent: October 20, 2020Assignee: Bigfoot Biomedical, Inc.Inventors: Lane Desborough, Bryan Mazlish
-
Patent number: 10780223Abstract: A method includes receiving up-to-date blood glucose data for a PWD, determining basal insulin dosages for the PWD based on a baseline basal rate, delivering the basal insulin dosages to the PWD, modifying a target blood glucose level based on variability of blood glucose data for the PWD, receiving a temporary override indicating a user preference to reduce the likelihood that the PWD has a hypoglycemic event or a user preference to reduce the likelihood that the PWD has a hyperglycemic event, determining a temporary target blood glucose level based on the input—greater than the modified blood glucose level if the preference is to reduce the likelihood of a hypoglycemic event—lower than the modified target blood glucose level if the preference is to reduce the likelihood that of a hyperglycemic event. The method includes delivering basal insulin for the temporary period of time based on the temporary target.Type: GrantFiled: January 13, 2017Date of Patent: September 22, 2020Assignee: Bigfoot Biomedical, Inc.Inventors: Lane Desborough, Bryan Mazlish
-
Patent number: 10758675Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include receiving and/or determining one or more user specific dosage parameters.Type: GrantFiled: January 12, 2018Date of Patent: September 1, 2020Assignee: Bigfoot Biomedical, Inc.Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
-
Patent number: 10758670Abstract: A variety of location-based and/or proximity-based features related to diabetes management systems can be used to improve maintenance compliance and/or to provide important information to PWD designated assistance entities (e.g., family, friends, givers, HCPs, emergency medicine providers) under certain conditions. In some cases, a user's location can be tracked or determined to trigger and/or time alerts about upcoming maintenance tasks in a way that will increase the likelihood that the PWD will immediately perform the designated maintenance task. In some cases, methods, devices, and systems provided herein can use proximity to non-paired mobile computing devices to deliver data to PWD designated assistance entities.Type: GrantFiled: March 1, 2019Date of Patent: September 1, 2020Assignee: Bigfoot Biomedical, Inc.Inventors: Jeffrey Brewer, Kevin S. Lee
-
Patent number: 10737015Abstract: Some embodiments an infusion pump system can be used to determine a user's total insulin load (TIL) that provides an accurate indication of the insulin previously delivered to the user's body which has not yet acted. In particular embodiments, the TIL can account for both the bolus deliveries and the basal deliveries that have occurred over a period of time. Such information may be useful, for example, when the infusion pump is operated in conjunction with a continuous glucose monitoring device.Type: GrantFiled: April 9, 2018Date of Patent: August 11, 2020Assignee: Bigfoot Biomedical, Inc.Inventor: Mark C. Estes
-
Patent number: 10716895Abstract: Some embodiments of an infusion pump system may be configured to detect when at least one component of the pump system is exposed to a moisture level above a threshold level. In particular embodiments, the infusion pump system can be equipped with a moisture level detection system that can sense when a moisture level above the threshold level has occurred to the pump device, which thereby enables the infusion pump system to initiate one or more patient safety countermeasures.Type: GrantFiled: August 18, 2016Date of Patent: July 21, 2020Assignee: BIGFOOT BIOMEDICAL, INC.Inventors: Tracy Brewer, Wenkang Qi, Johannes T. VandenCrommenacker
-
Patent number: 10661007Abstract: Some embodiments of an infusion pump system can be configured to provide improved safety monitoring features so that a user receives proper dosage amounts.Type: GrantFiled: August 18, 2016Date of Patent: May 26, 2020Assignee: Bigfoot Biomedical, Inc.Inventor: Mark C. Estes
-
Patent number: 10661008Abstract: Some embodiments of an infusion pump system include a pump device with a drive system that is configured to attach with a medicine cartridge in manner that reduces the likelihood of dosage inaccuracies. In one example, the drive system of the pump device can be equipped with a plunger engagement device that is configured to mechanically anchor into a plunger of the medicine cartridge, and then to bias the plunger of the medicine cartridge in a direction toward a piston rod of the drive system.Type: GrantFiled: February 7, 2018Date of Patent: May 26, 2020Assignee: Bigfoot Biomedical, Inc.Inventors: Tracy Brewer, Wenkang Qi
-
Patent number: 10632257Abstract: Some embodiments of a wearable infusion pump system can include a pump device having a drive system to dispense a medicine to a user, an activity sensor that detects a possible change in an activity level of the user, and a controller to activate the drive system to dispense the medicine to the user. The controller device can query the user to indicate whether a detected activity level of the user represents an actual change in the activity level of the user. The controller device can alter the medicine dispensing schedule based on the user indicated changes in activity level.Type: GrantFiled: November 2, 2018Date of Patent: April 28, 2020Assignee: Bigfoot Biomedical, Inc.Inventors: Mark C. Estes, Deb Ruppert
-
Patent number: 10636077Abstract: Some embodiments described herein provide for a number of portable infusion pumps to be distributed to a pump user via a pharmacy system or like.Type: GrantFiled: November 26, 2018Date of Patent: April 28, 2020Assignee: Bigfoot Biomedical, Inc.Inventor: Mark C. Estes
-
Patent number: 10610644Abstract: Methods of insulin delivery may include obtaining one or more blood glucose readings from a flash glucose monitor, where the blood glucose readings may be obtained in response to a user invocation of the flash glucose monitor. The method may also include generating multiple insulin delivery profiles of insulin delivery actions over multiple diurnal time segments based on the one or more blood glucose readings. The method may additionally include selecting one of the delivery profiles that is projected to approximate a target blood glucose level, and delivering insulin according to the selected delivery profile. Systems may provide such insulin delivery.Type: GrantFiled: January 12, 2018Date of Patent: April 7, 2020Assignee: Bigfoot Biomedical, Inc.Inventors: Bryan Mazlish, Lane Desborough
-
Patent number: 10610643Abstract: Methods, devices, and systems of delivering infusion fluid (e.g., medication such as insulin) can detect, at multiple times during a dispensation period of time, a pressure level of the infusion fluid in an infusion fluid pathway, either directly or indirectly. Based on the detected pressure levels, one or more actual dispensation times that are after an intended dispensation time can be determined. In some cases, methods, devices, and systems provided herein can use variable occlusion alarm thresholds, which can depend on variables such as an age of an infusion set and/or a current analyte level. In some cases, methods, devices, and systems provided herein can automate medication delivery and use the actual dispensation times in a control algorithm determining medication deliveries.Type: GrantFiled: January 12, 2017Date of Patent: April 7, 2020Assignee: Bigfoot Biomedical, Inc.Inventors: Bryan Mazlish, Lane Desborough, Ravi Shankar Rontala Raghunathan
-
Patent number: 10603431Abstract: Some embodiments of an infusion pump device may include a drive system that accurately and incrementally dispenses fluid from the pump device in a controlled manner. Particular embodiments of the drive system may include a rotational motor that is coupled to a string member, which is used to adjust a pawl relative to a ratchet body. In such circumstances, the drive system can provide a reliable and compact infusion pump device that accurately dispenses the desired volume of fluid.Type: GrantFiled: October 13, 2017Date of Patent: March 31, 2020Assignee: Bigfoot Biomedical, Inc.Inventors: Morten Mernoe, Mitchell Wenger, James Causey, Todd Kirschen
-
Patent number: 10603433Abstract: Some embodiments an infusion pump system can be configured to control dispensation of medicine according to a closed-loop delivery mode that is responsive to feedback information provided from a monitoring device, and the infusion pump system permits a user to interrupt the closed-loop delivery mode for purposes of dispensing a user-selected manual bolus dosage.Type: GrantFiled: December 20, 2017Date of Patent: March 31, 2020Assignee: Bigfoot Biomedical, Inc.Inventor: Mark C. Estes
-
Patent number: 10583250Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include adjusting user specific dosage parameters in response to one or more back-filled time segments associated with a diurnal time block.Type: GrantFiled: January 12, 2018Date of Patent: March 10, 2020Assignee: Bigfoot Biomedical, Inc.Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
-
Patent number: 10576204Abstract: Some embodiments of an infusion pump system can include a controller in which one or more features sets to be provided by the controller are enabled or disabled based upon the particular pump device that is connected to the controller. For example, in some embodiments, one or more advanced features of the controller are available to the user only when a first type of pump device (e.g., having predefined settings stored therein) is connected to the controller, and those advanced features of the controller are disabled when a second type of pump device is connected to the controller.Type: GrantFiled: September 25, 2017Date of Patent: March 3, 2020Assignee: Bigfoot Biomedical, Inc.Inventors: Mark C. Estes, Wenkang Qi, Phillip Hopper
-
Patent number: 10569015Abstract: Some embodiments of an infusion pump system may be configured to allow the user to communicate with the infusion pump system using voice or image input. Optionally, particular embodiments can interpret the voice or image input using speech or image recognition capabilities. By incorporating speech or image recognition equipment within the infusion pump system, user interactions with the pump system can be enhanced and simplified.Type: GrantFiled: December 2, 2013Date of Patent: February 25, 2020Assignee: Bigfoot Biomedical, Inc.Inventor: Mark C. Estes
-
Patent number: D889638Type: GrantFiled: April 30, 2018Date of Patent: July 7, 2020Assignee: BIGFOOT BIOMEDICAL, INC.Inventors: George Crothall, Charles R. Lewis, Jr., Jeffrey Michael Johnson, Per John Sjölund, Sarah Matarese, Ambika Srinath, Andrew Bochenko